methionine has been researched along with nvc-422 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, M; Debabov, D; Jekle, A; Khosrovi, B; Memarzadeh, B; Najafi, R; Ruado, F; Wang, L; Yoon, J; Zuck, M | 1 |
| Anderson, M; Debabov, D; Eitzinger, C; Francavilla, C; Jekle, A; Nagl, M; Najafi, R; Rani, SA; Shiau, T; Wang, L; Yoon, J; Zuck, M | 1 |
2 other study(ies) available for methionine and nvc-422
| Article | Year |
|---|---|
Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Antiviral Agents; Cell Line; Conjunctivitis, Viral; Cysteine; Humans; Methionine; Oxidation-Reduction; Sulfhydryl Compounds; Taurine; Viral Proteins; Virus Inactivation; Virus Replication | 2011 |
NVC-422 inactivates Staphylococcus aureus toxins.
Topics: Anti-Infective Agents; Bacterial Toxins; Cell Proliferation; Cytokines; Enterotoxins; Exfoliatins; Methionine; Oxidation-Reduction; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus; Superantigens; Taurine | 2013 |